Northwest Biotherapeutics reported -10049000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Applied Genetic Technologies AGTC:US $ -16.42M 2.64M
AstraZeneca AZN:LN -1674000000 2.8B
Bristol Myers Squibb BMY:US $ 1996M 281M
Celldex Therapeutics CLDX:US $ -20.82M 7.38M
Cti Biopharma CTIC:US $ -23.38M 3.88M
Cytori Therapeutics CYTX:US $ -3499000 924K
Cytrx CYTR:US -1532610 351.4K
Eisai 4523:JP Y 5499M 49908M
Genocea Biosciences GNCA:US $ -11.72M 2.83M
Infinity Pharmaceuticals INFI:US $ -10.75M 0.5M
Merk MRK:US $ 4826M 3212M
Mirati Therapeutics MRTX:US $ -79.5M 84.69M
Northwest Biotherapeutics NWBO:US -10049000 2.49M
Pfizer PFE:US $ 7647M 1733M
Sunesis Pharmaceuticals SNSS:US $ -14.8M 5.74M